Concord Biotech is an India-based biopharma company and one of the leading global developers and manufacturers of select fermentation-based APIs across immunosuppressants and oncology, supplying 200 customers in over 70 countries including regulated markets, such as the United States, Europe and Japan, and India.
In 2016, the company launched its formulation business in India as well as emerging markets, including Nepal, Mexico, Indonesia, Thailand, Ecuador, Kenya, Singapore and Paraguay, and have further expanded to the United States.
As of March 31, 2022, the company has six fermentation-based immunosuppressant APIs, including tacrolimus, mycophenolate mofetil, mycophenolate sodium, cyclosporine, sirolimus and pimecrolimus.
- Anti-infective APIs. Concord Biotech anti-infective APIs include:
- Anti-bacterial APIs: the company offer four anti-bacterial APIs, including mupirocin, mupirocin calcium, vancomycin hydrochloride and teicoplanin;
- Anti-fungal APIs: The company offer three anti-fungal APIs, including anidulafungin, micafungin sodium and caspofungin; and
- Oncology drug APIs. Concord Biotech offer six oncology drug APIs, including temsirolimus, everolimus, romidepsin, mitomycin, dactinomycin and midostaurin.
Concord Biotech IPO – Details
| IPO Opening Date | 04 August 2023 |
| IPO Closing Date | 08 August 2023 |
| Issue Type | Book Built Issue IPO |
| Issue Size | 2,09,25,652 Shares Worth ₹1550.59 Crore Offer For Sale: 2,09,25,652 Shares Worth ₹1550.59 Crore |
| Face Value | ₹1 per equity share |
| IPO Price | ₹705 – ₹741 |
| Market Lot | 20 Shares |
| Min Order | 20 Shares (1 Lot) |
| Employee Discount | ₹70 Per Share |
| Listing At | BSE, NSE |
| Register | Link Intime India Private Limited |
| QIB Shares Offered | 50% |
| NII (HNI) Shares Offered | 15% |
| Retail Shares Offered | 35% |
Concord Biotech IPO – Date Schedule
| IPO Open Date | 04 August 2023 |
| IPO Close Date | 08 August 2023 |
| Basis of Allotment Date | 11 August 2023 |
| Initiation of Refunds | 14 August 2023 |
| Credit of Shares to Demat Account | 17 August 2023 |
| IPO Listing Date | 18 August 2023 |
| Cut-off time for UPI mandate confirmation | 5 PM on 08 August , 2023 |
Concord Biotech IPO – Lots Size & Price
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 20 | 14,820 |
| Retail (Max) | 13 | 260 | 1,92,660 |
| S-HNI (Min) | 14 | 280 | 2,07,480 |
| S-HNI (Max) | 67 | 1340 | 9,92,940 |
| B-HNI (Min) | 68 | 1360 | 10,07,760 |
Competitive Strengths
- Established presence across the complex fermentation value chain;
- Global leadership in immunosuppressant APIs along with a wide spectrum of complex fermentation-based APIs across multiple therapeutic areas;
- Scaled manufacturing facilities with a consistent regulatory compliance track record and supported by strong R&D capabilities;
- Diversified global customer base with long-standing relationships with key customers;
- Experienced Promoters, management team supported by marquee investors;
- Financial track record of rapid growth and consistent profitability with healthy cash flows and strong shareholder returns.
Company Promoters
- Sudhir Vaid
- Ankur Vaid
Company Financials
| Particulars | Total Revenue | Total Expense | Profit After Tax | Total Borrowing |
|---|---|---|---|---|
| 31 March 2020 | 543.59 | 330.10 | 169.11 | 48.02 |
| 31 March 2021 | 630.75 | 317.58 | 234.88 | 86.34 |
| 31 March 2022 | 736.34 | 495.19 | 174.92 | 60.58 |
| 31 March 2023 | 888.47 | 568.42 | 240.08 | 31.23 |
Key Performance Indicator
| KPI | Values |
|---|---|
| P/E | 32.29 |
| Market Cap (₹ Cr.) | 7752.06 |
| ROE | 20.06 |
| ROCE | 24.27 |
| EPS (Rs) | 20.79 |
| RoNW | 20.00 |
Object Of The Issue
- Achieve the benefits of listing the Equity Shares on the Stock Exchanges;
- Carry out the Offer for Sale of up to 20,925,652 Equity Shares by the Selling Shareholder.
Concord Biotech IPO Peer Comparison
| S. No. | Face Value | Company Name | PE |
| 1 | 2 | Divi’s Laboratories Limited | 54.15 |
| 2 | 1 | Suven Pharmaceuticals Limited | 30.08 |
| 3 | 2 | Laurus Labs Limited | 23.70 |
| 4 | 1 | Shilpa Medicare Limited | – |
Concord Biotech IPO Promoter Holding
| Pre Issue Share Holding | 44.08% |
| Post Issue Share Holding | 44.08% |
Concord Biotech IPO Prospectus
Company Contact Information
| Concord Biotech Limited 1482-86, Trasad Road Dholka, Ahmedabad – 382225, Gujarat, India Phone: 079-6813 8700 Email: complianceofficer@concordbiotech.com Website: www.concordbiotech.com |
Concord Biotech IPO Registrar
| Link Intime India Private Limited Phone: +91 22 4918 6200 Email: : concordbiotech.ipo@linkintime.co.in Website: https://linkintime.co.in/mipo/ipoallotment.html |
Concord Biotech IPO Lead Manager(s)
| 1. Jefferies India Private Limited 2. Citigroup Global Markets India Private Limited 3. Kotak Mahindra Capital Company Limited |
Concord Biotech IPO FAQs
| What is Concord Biotech IPO? Concord Biotech IPO is a main-board IPO. The issue is priced at ₹705 to ₹741 per equity share. The IPO is to be listed on BSE & NSE. |
| When Concord Biotech IPO will open? The IPO is to open on 04 August 2023 for QIB, NII, and Retail Investors. |
| What is Concord Biotech IPO Investors Portion? The investors’ portion for QIB – 50%, NII – 15%, and Retail – 35%. |
| How to Apply the Concord Biotech IPO? You can apply Concord Biotech IPO via ASBA online via your bank account. You can also apply for ASBA online via UPI through your stock brokers. You can also apply via your stock brokers by filling up the offline form. |
| How to Apply the Concord Biotech IPO through Angle One? Log in to Angle One Application with your credentials. Select the IPO. You will see the IPO Name “Concord Biotech”. Click on Bid Button. Confirm your Application. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate. Open Demat Account with Angle One. |
| How to Apply the Concord Biotech IPO through 5 Paisa? Log in to 5 Paisa Application with your credentials. Select the IPO. You will see the IPO Name “Concord Biotech”. Click on Bid Button. Confirm your Application. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate. Open Demat Account with 5 Paisa. |
| How to Apply the Concord Biotech IPO through Upstox? Log in to Upstox Application with your credentials. Select the IPO. You will see the IPO Name “Concord Biotech”. Click on Bid Button. Confirm your Application. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate. Open Demat Account with Upstox. |
| How to Apply the Concord Biotech IPO through IIFL? Log in to IIFL Application with your credentials. Select the IPO. You will see the IPO Name “Concord Biotech”. Click on Bid Button. Confirm your Application. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate. Open Demat Account with IIFL. |
| What is Concord Biotech IPO Size? Concord Biotech IPO size is ₹1550.59 Cr. |
| What is Concord Biotech IPO Price Band? Concord Biotech IPO Price Band is ₹705 to ₹741. |
| What is Concord Biotech IPO Minimum and Maximum Lot Size? The minimum bid is 20 Shares with ₹14,820 amount while the maximum bid is 260 shares with ₹1,92,660. |
| What is the Concord Biotech IPO Allotment Date? Concord Biotech IPO allotment date is 14 August 2023. |
| What is the Concord Biotech IPO Listing Date? Concord Biotech IPO listing date is 18 August 2023. The IPO is to list on BSE and NSE. |
